Twist Bioscience Faces Financial Turbulence Despite Leading Synthetic DNA Innovation
Twist Bioscience’s rise in synthetic DNA tech is hampered by sharp stock volatility and losses—can the biotech pioneer turn innovation into sustainable profit?
2 minutes to read
